Navigation Links
DRAXIS Health Reports Fourth Quarter and Year End Results
Date:2/7/2008

of 2007 compared to the significant lower

levels of the third quarter of 2007. Nevertheless, as expected,

Hectorol(R) volumes did not achieve the record levels of 2006 and in

particular the fourth quarter of 2006.

Included in this segment's revenues for the quarter are

approximately $0.9 million ($2.6 million for 2007) in product

transfer activities related to the Company's new Johnson & Johnson

Consumer contract.

- Product gross margin percentage decreased to 27% in the fourth

quarter and to 24% for 2007 compared to 39% and 36%, respectively,

for the same periods of 2006. The decrease was driven by lower

sterile volumes impacting margins through lower plant utilization

and a lower percentage of sterile volumes as part of the overall

product mix.

- Operating income for the fourth quarter of 2007 was $0.2 million and

for 2007 was $2.6 million compared to operating income of

$4.2 million and $13.0 million respectively for the same periods in

2006 due to lower sterile volumes and increased severance costs,

partially offset by a revaluation of incentive awards.

- During the fourth quarter of 2007, the contract manufacturing

division continued to implement procedures to reduce production

delays that have in the past resulted in shipments not being

released in a timely manner, impacting quarterly results for most of

2007. While the Company has made improvements in expediting the

process times for orders, shifting customer shipment schedules and

reprioritizing projects associated with organizational changes, the

improvements have to date only partially removed the backlog of

built-up demand. The procedures being put in place to remove the

backlog of demand and to improve t
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... The American Brain Tumor Association is ... Research Fellowships and 2014-2015 Discovery Grant Awards. Through the ... the field with talented, bright young investigators who have ... effects, diagnosis and treatment of brain tumors. This year’s ... the potential to advance the understanding and treatment of ...
(Date:8/27/2014)... to help regulate the blood,s iron supply shows promise as ... results from the first human study of the ... the Journal of the American Society of Hematology ... cells are in short supply or do not function properly. ... enough oxygen, since there are fewer red blood cells to ...
(Date:8/27/2014)... trial participation in the largest ongoing observational study of ... representative of the larger patient base, according to a ... Udell. The study authors call into question the general ... suggest the use of broader enrollment criteria and existing ... that clinical trials can be tremendously expensive and a ...
(Date:8/27/2014)... University,s Center for Leadership in Disability (CLD) has ... and Child Health Bureau of the Health Resources ... Autism Plan for Georgia, aimed at improving services ... , In preparing for this project, CLD worked ... stakeholders from across Georgia. The resulting plan addresses ...
(Date:8/27/2014)... August 27, 2014 Jaha was founded with ... Jaha invested in creating the industry’s most affordable fitness tracker ... that no other apps possess. Jaha plans to ... differentiates in three simple steps: locate, challenge and motivate. ... Aug 26, 2014 to garner support and to raise awareness ...
Breaking Medicine News(10 mins):Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Drug represents first potential treatment for common anemia 2Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2
... study has shown that children, who are exposed to smoke, ... are likely to have impaired vitamin C levels. Earlier studies ... study, which involved 520 children aged 2 to 12 years, ... have plasma ascorbate concentrations that were lower by an average ...
... the recent past have argued about the implications of Hormone ... menopausal symptoms. A new study, however, has gone further to ... risk of developing breast cancer// if they consumed alcoholic beverages. ... alcohol consumption pattern and on whether they were on HRT ...
... immediately prior to menopause beginning with normal, biological, and ... menstrual periods, is a time of increased vulnerability to ... disorders. Earlier studies have shown that women who experienced ... two to three times more likely to have had ...
... A recent study called 'HERS' conducted by researchers of the ... women, has found that Hormone Replacement Therapy (HRT) may be ... go on to develop diabetes as well. ,The study ... did not or had "impaired fasting glucose" - a ...
... is almost an established truth now. However, many of us ... of pizza could do to our overall health. A recent ... //for Science in the Public Interest (CSPI), which involved 36 ... and looked at dietary information provided by four famous pizza ...
... in the Institute of Preventive Medicine in Copenhagen suggests ... dementia and Alzheimer's disease. Scientists, who found// that people ... two times less likely to develop dementia, said that ... in wine which reduce the occurrence of dementia. This ...
Cached Medicine News:Health News:Women on HRT should avoid alcohol 2Health News:Depressed women show signs of earlier onset of Perimenopause 2Health News:Pizza is bad for health. But, do you know how bad? 2
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... DIEGO , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... and development of drugs targeting unmet needs in oncology, autoimmune ... Baird 2014 Health Care Conference to be held at The ... on September 3-4, 2014. Alan ... Company and its lead drug candidate, quizartinib, at 1:10 p.m. ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... Oramed Pharmaceuticals, Inc.,(OTCBB: ORMP.OB) ( http://www.oramed.com ), a ... to present at the 8th National Life,Science & Technology ... by Mr. Nadav Kidron, President and CEO of Oramed,on ... p.m. (local time),at the David Intercontinental Hotel in Tel-Aviv, ...
... Patients Demonstrated Improvement With Every-Four-Week Subcutaneous SIMPONI Despite ... , COPENHAGEN, June 9 A new analysis ... moderately to severely active rheumatoid arthritis (RA) who ... agents and received subcutaneous injections of SIMPONI(TM) (golimumab) ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 3New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 4New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 5New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 6New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 7New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 8New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 9New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 10
... Littmann Electronic Stethoscope Model 4100WS features amplification ... allowing you to reduce ambient noise by ... critical body sounds. Three frequency modes are ... other body sounds: Bell (20-200 Hz), Diaphragm ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
... is a portable, battery-powered bone growth stimulator used ... device is worn for 30 minutes each day ... fusion site. The device uses a unique technology, ... energy signal that is very potent in its ...
... is a multi-site, implantable biventricular ... and two ventricular ports for ... (AF) who have undergone an ... have NYHA Class II or ...
Medicine Products: